More than a quarter of adults worldwide could benefit from GLP-1 medications for weight loss, study finds

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like diabetes, cardiovascular disease, and cancers. This public health crisis strains global health care systems and economies, but a new study co-led by investigators from Mass General Brigham could inform strategic programs to make GLP-1 medications part of the solution.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup